These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 26384012)
1. Association of NOS1AP variants and depression phenotypes in schizophrenia. Cheah SY; Lawford BR; Young RM; Morris CP; Voisey J J Affect Disord; 2015 Dec; 188():263-9. PubMed ID: 26384012 [TBL] [Abstract][Full Text] [Related]
2. The interaction of NOS1AP, DISC1, DAOA, and GSK3B confers susceptibility of early-onset schizophrenia in Chinese Han population. Hu G; Yang C; Zhao L; Fan Y; Lv Q; Zhao J; Zhu M; Guo X; Bao C; Xu A; Jie Y; Jiang Y; Zhang C; Yu S; Wang Z; Li Z; Yi Z Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():187-193. PubMed ID: 29100974 [TBL] [Abstract][Full Text] [Related]
3. NOS1AP is associated with increased severity of PTSD and depression in untreated combat veterans. Lawford BR; Morris CP; Swagell CD; Hughes IP; Young RM; Voisey J J Affect Disord; 2013 May; 147(1-3):87-93. PubMed ID: 23146198 [TBL] [Abstract][Full Text] [Related]
5. Nitric oxide pathway genes (NOS1AP and NOS1) are involved in PTSD severity, depression, anxiety, stress and resilience. Bruenig D; Morris CP; Mehta D; Harvey W; Lawford B; Young RM; Voisey J Gene; 2017 Aug; 625():42-48. PubMed ID: 28465168 [TBL] [Abstract][Full Text] [Related]
6. Evidence for a role of the NOS1AP (CAPON) gene in schizophrenia and its clinical dimensions: an association study in a South American population isolate. Kremeyer B; García J; Kymäläinen H; Wratten N; Restrepo G; Palacio C; Miranda AL; López C; Restrepo M; Bedoya G; Brzustowicz LM; Ospina-Duque J; Arbeláez MP; Ruiz-Linares A Hum Hered; 2009; 67(3):163-73. PubMed ID: 19077434 [TBL] [Abstract][Full Text] [Related]
7. Lack of association between PKLR rs3020781 and NOS1AP rs7538490 and type 2 diabetes, overweight, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits. Andreasen CH; Mogensen MS; Borch-Johnsen K; Sandbaek A; Lauritzen T; Almind K; Hansen L; Jørgensen T; Pedersen O; Hansen T BMC Med Genet; 2008 Dec; 9():118. PubMed ID: 19111066 [TBL] [Abstract][Full Text] [Related]
8. The genetic contribution of the NO system at the glutamatergic post-synapse to schizophrenia: further evidence and meta-analysis. Weber H; Klamer D; Freudenberg F; Kittel-Schneider S; Rivero O; Scholz CJ; Volkert J; Kopf J; Heupel J; Herterich S; Adolfsson R; Alttoa A; Post A; Grußendorf H; Kramer A; Gessner A; Schmidt B; Hempel S; Jacob CP; Sanjuán J; Moltó MD; Lesch KP; Freitag CM; Kent L; Reif A Eur Neuropsychopharmacol; 2014 Jan; 24(1):65-85. PubMed ID: 24220657 [TBL] [Abstract][Full Text] [Related]
9. An association analysis of synapse-associated protein 97 (SAP97) gene in schizophrenia. Sato J; Shimazu D; Yamamoto N; Nishikawa T J Neural Transm (Vienna); 2008 Sep; 115(9):1355-65. PubMed ID: 18665322 [TBL] [Abstract][Full Text] [Related]
10. Sex is a moderator of the association between NOS1AP sequence variants and QTc in two long QT syndrome founder populations: a pedigree-based measured genotype association analysis. Winbo A; Stattin EL; Westin IM; Norberg A; Persson J; Jensen SM; Rydberg A BMC Med Genet; 2017 Jul; 18(1):74. PubMed ID: 28720088 [TBL] [Abstract][Full Text] [Related]
12. Interaction of multiple gene variants and their effects on schizophrenia phenotypes. Cheah SY; Lurie JK; Lawford BR; Young RM; Morris CP; Voisey J Compr Psychiatry; 2016 Nov; 71():63-70. PubMed ID: 27636509 [TBL] [Abstract][Full Text] [Related]
13. Mutation screening of NOS1AP gene in a large sample of psychiatric patients and controls. Delorme R; Betancur C; Scheid I; Anckarsäter H; Chaste P; Jamain S; Schuroff F; Nygren G; Herbrecht E; Dumaine A; Mouren MC; Råstam M; Leboyer M; Gillberg C; Bourgeron T BMC Med Genet; 2010 Jul; 11():108. PubMed ID: 20602773 [TBL] [Abstract][Full Text] [Related]
14. Positive association between rs10918859 of the NOS1AP gene and coronary heart disease in male Han Chinese. Huang Y; Lian J; Huang RS; Wang F; Xu L; Le Y; Yang X; Xu W; Huang X; Ye M; Zhou J; Duan S Genet Test Mol Biomarkers; 2013 Jan; 17(1):25-9. PubMed ID: 23171141 [TBL] [Abstract][Full Text] [Related]
15. Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam Study. Aarnoudse AJ; Newton-Cheh C; de Bakker PI; Straus SM; Kors JA; Hofman A; Uitterlinden AG; Witteman JC; Stricker BH Circulation; 2007 Jul; 116(1):10-6. PubMed ID: 17576865 [TBL] [Abstract][Full Text] [Related]
16. [Association of Schizophrenia and its Clinical Implications with the NOS1AP Gene in the Colombian Population]. Valencia JG; Duarte AV; Vila AL; Kremeyer B; Montoya MP; Linares AR; Acosta CA; Duque JO; Berrío GB Rev Colomb Psiquiatr; 2012 Jun; 41(2):249-72. PubMed ID: 26573492 [TBL] [Abstract][Full Text] [Related]
17. Neuronal nitric oxide synthase (NOS1) and its adaptor, NOS1AP, as a genetic risk factors for psychiatric disorders. Freudenberg F; Alttoa A; Reif A Genes Brain Behav; 2015 Jan; 14(1):46-63. PubMed ID: 25612209 [TBL] [Abstract][Full Text] [Related]
18. Further evidence for a male-selective genetic association of synapse-associated protein 97 (SAP97) gene with schizophrenia. Uezato A; Kimura-Sato J; Yamamoto N; Iijima Y; Kunugi H; Nishikawa T Behav Brain Funct; 2012 Jan; 8():2. PubMed ID: 22225629 [TBL] [Abstract][Full Text] [Related]
19. Influence of NOS1AP Risk Variants on the Corrected QT (QTc) Interval in the Pharmacotherapy of Schizophrenia. Esen-Sehir D; Kopf J; Hägele S; Plichta MM; Reif A; Freudenberg F Pharmacopsychiatry; 2022 Sep; 55(5):266-273. PubMed ID: 35732169 [TBL] [Abstract][Full Text] [Related]
20. Nitric oxide synthase 1 adaptor protein, a protein implicated in schizophrenia, controls radial migration of cortical neurons. Carrel D; Hernandez K; Kwon M; Mau C; Trivedi MP; Brzustowicz LM; Firestein BL Biol Psychiatry; 2015 Jun; 77(11):969-78. PubMed ID: 25542305 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]